Tumor suppression without differentiation or apoptosis by antisense cyclin D1 gene transfer in K1735 melanoma involves induction of p53, p21WAF1 and superoxide dismutases

Cell Death and Differentiation

Volumn 6, Issue 12, 1999, Pages 1209-1215

  Rieber, M ^a   Rieber, M Strasberg ^a  

^a INSTITUTO VENEZOLANO DE INVESTIGACIONES CIENTÍFICAS   (Venezuela)

Author keywords

Anti oxidant enzymes; Growth retardation; p53 p21 pathway

Indexed keywords

BETA GALACTOSIDASE; COMPLEMENTARY DNA; CYCLIN D1; MONOPHENOL MONOOXYGENASE; PEROXIDASE; PROTEIN P21; PROTEIN P53; SUPEROXIDE DISMUTASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER INHIBITION; CELL DIFFERENTIATION; CONTROLLED STUDY; ENZYME INDUCTION; GENE TRANSFER; MELANOMA; MOUSE; NONHUMAN; PIGMENTATION; PRIORITY JOURNAL; PROTEIN INDUCTION; RETROVIRUS;

ANIMALIA; MAMMALIA; UNIDENTIFIED RETROVIRUS;

EID: 0343049031     PISSN: 13509047     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.cdd.4400606     Document Type: Article

References (39)

1. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, Medrano EE, Linskens M, Rubelj I, Pereira-Smith O, Peacocke M and Campisi J (1995) A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92: 9363-9367.
2. Atadja P, Wong H, Garkavtsev I, Veillette C and Riabowol K (1995) Increased activity of p53 in senescing fibroblasts. Proc. Natl. Acad. Sci. USA 92: 8348-8352.
3. Serrano M, Lin AW, McCurrach ME, Beach D and Lowe SW (1997) Oncogenic ras provokes Premature Cell Senescence Associated with Accumulation of p53 and p16 INK4A. Cell 88: 593-602.
4. Sugrue MM, Shin DY, Lee SW and Aaronson SA (1997) Wild type p53 triggers a rapid senescence program in human tumors lacking functional p53. Proc. Natl. Acad. Sci. USA 94: 9648-9653.
5. Noda A, Ning Y, Venable SF, Pereira-Smith OM and Smith JR (1994) Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp. Cell Res. 211: 90-98.
6. El Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trant JM, Lin D, Lercer WE, Kinzler KW and Vogelstein BE (1993) WAF1, a potential mediator of p53 tumor suppressor. Cell 75: 817-825.
7. HarperJW, Adami GR, Wei N, Keyomarsi K and Elledge SJ (1993)Thep21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75: 805-816.
8. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R and Beach D (1993) p21 is a universal inhibitor of cyclin kinase. Nature 366: 701-704.
9. Polyak K, Xia Y, Zweier JL, Kinzler KW and Vogelstein B (1997) A model for p53-induced apoptosis. Nature 389: 300-305.
10. Chen Q and Ames BN (1994) Senescence-like growth arrest induced by hydrogen peroxide in human diploid fibroblast F65 cells. Proc. Natl. Acad. Sci. USA 91: 4130-4134.
11. Oberley LW and Oberley TD (1988) Role of anti-oxidant enzymes in cell immortalization and transformation. Mol. Cell. Biochem. 84: 147-153.
12. Alvarez M, Strasberg Rieber M and Rieber M (1998) Chromosome 6-mediated Suppression of Metastatic ability increases basal expression of UV-inducible Superoxide Dismutase and p53. Int. J. Cancer 77: 586-591.
13. Church SL, Grant SW, Ridnour LA, Oberley LW, Swanson PE, Meltzer PS and Trent JM (1993) Increased manganese superoxide dismutase expression suppresses the malignant phenotype of human melanoma cells. Proc. Natl. Acad. Sci. USA 90: 3113-3117.
14. a in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA 93: 13742-13747.
15. Uhrbom L, Nister M and Westermark B (1997) Induction of senescence in human malignant glioma cells by p16INI4A. Oncogene 15: 505-514.
16. Bartkova J, Lukas J, Guldberg G, Alsner J, Kirkin AF, Zeuthen J and Bartek J (1996) The p16-cyclin D/cdk 4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res. 56: 5475-5483.
17. Castellano M, Pollock PM, Walers MK, Sparrow LE, Down LM, Gabrielli BG, Parsons PG and Hayward NK (1997) CDK2A/p16 is inactivated in most Melanoma lines. Cancer Res. 57: 4868-4875.
18. Strasberg Rieber M and Rieber M (1993) Specific Tyrosinases associated with Melanoma Replicative Senescence and Melanogenesis. Cancer Res. 53: 2469-2471.
19. Strasberg Rieber M and Rieber M (1995) Suppression of Cyclir D1 but not cdk4 or Cyclin A with induction of Melanoma Terminal Differentiation. Biochem. Biophys. Res. Comm. 216: 422-427.
20. Olson E (1992) Interplay between proliferation and different ation within the myogenic lineage. Dev. Biol. 154: 261-272.
21. Weinstat Saslow D, Merino MJ, Manrow RE, Lawrence JA, Bluth RF, Wittenbel KD, Simpson JF, Page DL and Steeg PS (1995) Overexpression of cyclin D mRN A distinguishes invasive and in situ breast carcinomas from non-malignant lesions. Nature Medicine 1: 1257-1260.
22. Arber N, Doki Y, Man EK, Sgambato A, Zhou P, Kim N-H, DeloheryT, Klein MG, Holt PR and Weinstein IB (1997) Antisense to cyclin D1 inhibits the Growth and Tumorigenicity of Human Colon Cancer Cells. Cancer Res. 57 1569-1574.
23. XieK, Wang Y, Huang S, Xu L, Bielenberg D, Salas T, McConkey DJ, Jiang W and Fidler IJ (1997) Nitric oxide-mediated apoptosis of K1735 melanoma is associated with down-regulation of bcl-2. Oncogene 15: 771-779.
24. de Haan JB, Cristiano F, lannello R, Bladier C, Keiner MJ amd Kola I (1996) Elevation in the ratio of Cu/Zn-superoxide dismutase to glutathione peroxidase activity induces features of cellular senescence and this effect is mediated by hydrogen peroxide. Human Mol. Gen. 5: 283-292.
25. Petersen W, Ronnov-Jessen L, Weaver VM and Bisell MJ (1998) Differentiation and cancer in the mammary gland-shedding light on an old dichotomy. Adv. Cancer Res. 75: 135-161.
26. Driscoll B, Wu L, Buckley S, Hall FL, Anderson KD and Warburton D (1997) Cyclin D1 antisense RNA destabilizes pRb and retards lung cancer cell growth. Am. J. Physiol. 273: L941-L949.
27. Toyoshima H and Hunter T (1994) p27, A novel inhibitorof G1 Cyclin-Cdk protein Kinase Activity, is related to p21. Cell 78: 67-74.
28. Ezhevsky SA, Toyoshima H, Hunter T and Scott SW (1996) Role of cyclin A and p27 in anti-IgM induced G1 growth arrest of murine B cell lymphomas. Mol. Biol. Cell. 7: 553-584.
29. Pieper AA, Verma A, Zhang J, Snyder SH (1999) Poly (ADP-ribose) polymerase, nitric oxide and cell death. Trends Pharmacol. Sci. 20:171-181.
30. Stein GH, Drullinger LF, Robetorye RS, Pereira-Smith O and Smith JR (1991) Senescent cells fail to express cdc2,cyc A and eye B in response to mitogen stimulation. Proc. Natl. Acad. Sci. USA 88: 11012-11016.
31. Jansen-Durrer P, Meichle A, Steiner P, Pagano M, Finke K, Botz J, Wessbecher J, Draetta G and Eilers M (1993) Differential modulation of cyclin gene expression by MYC. Proc. Natl. Acad. Sci. USA 90: 3685-3688.
32. Barlat I, Fesquet D, Brechot C, Henglein B, Dupuy d'Angeac A, Vie A and Blanchard JM (1993) Loss of the G1-S control of cyclin A expression during tumoral progression of Chinese hamster lung fibroblasts. Cell Growth and Diff. 4: 105-113.
33. Rieber M and Strasberg Rieber M (1994) Cyclin-dependent kinase 2 and cyclin A interaction with E2F are targets for tyrosine induction of B16 me anoma terminal differentiation. Cell Growth and Diff. 5: 1339-1346.
34. Danielsen T, Hvidsten M, Stokke T, Solberg K, Rofstad EK (1998) Hypoxia induces p53 accumulation in the S-phase and accumulation of hypophosphorylated retinoblastoma protein in all cell cycle phases of human melanoma cells. Br. J. Cancer 78: 1547-1558.
35. Pappolla MA, Chyan YJ, Omar RA, Hsiao K, Perry G, Smith MA and Bozner P (1998) Evidence of oxidative stress and in vivo neurotoxicity of beta-amyloid in a transgenic mouse model of Alzheimer's disease: a chronic oxidative paradigm for testing antioxidant therapies in vivo. Am. J. Pathol. 152: 871-877.
36. Walker GJ, Flores JF, Glendening JM, Lin AH, Markl ID and Fountain JW (1998) Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2, CDKN2B, or one of their downstream targets. Genes Chromosomes Cancer 22: 157-163.
37. Rieber M and Strasberg Rieber M (1998) Induction of p53 and Melanoma Cell Death is reciprocal with Down-regulation of E2F, cyclin D1 and pRb. Int. J. Car cer 76: 757-760.
38. Coupland SE, Bechrakis N, Schuler A, Anagnostopoulos I, Hummel M, Bornfield N, Stein H (1998) Expression patterns of cyclin D1 and related proteins regulating G1-S phase transition in uveal melanoma and retinoblastoma. Br. J. Ophthalmol. 82: 961-970.
39. Vile RG, Diaz RM, Miller N, Mitchell S, Tuszyanski A and Russell SJ (1995) Tissue-specific Gene expression from Mo-MLV Retroviral Vectors with Hybrid LTRs containing the Murine Tyrosinase Enhancer/Promoters. Virology 214: 307-313.